Summit Tx Capital, L.P. Ultragenyx Pharmaceutical Inc. Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q1 2025
A detailed history of Summit Tx Capital, L.P. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 20,085 shares of RARE stock, worth $699,761. This represents 0.03% of its overall portfolio holdings.
Number of Shares
20,085Holding current value
$699,761% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding RARE
# of Institutions
333Shares Held
89MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$348 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$195 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$145 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$112 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$91.2 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.44B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...